These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 17602782

  • 1. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.
    Kusaba M, Nakao K, Goto T, Nishimura D, Kawashimo H, Shibata H, Motoyoshi Y, Taura N, Ichikawa T, Hamasaki K, Eguchi K.
    J Hepatol; 2007 Oct; 47(4):546-55. PubMed ID: 17602782
    [Abstract] [Full Text] [Related]

  • 2. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF, Chen HL, Liu CY, Tai WT, Ichikawa K, Chen PJ, Cheng AL.
    Biochem Pharmacol; 2012 Mar 15; 83(6):769-77. PubMed ID: 22230479
    [Abstract] [Full Text] [Related]

  • 3. Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells.
    Fuke H, Shiraki K, Sugimoto K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Masuya M, Takei Y.
    Biochem Biophys Res Commun; 2007 Nov 23; 363(3):738-44. PubMed ID: 17904524
    [Abstract] [Full Text] [Related]

  • 4. DHMEQ, a novel NF-kappaB inhibitor, induces apoptosis and cell-cycle arrest in human hepatoma cells.
    Nishimura D, Ishikawa H, Matsumoto K, Shibata H, Motoyoshi Y, Fukuta M, Kawashimo H, Goto T, Taura N, Ichikawa T, Hamasaki K, Nakao K, Umezawa K, Eguchi K.
    Int J Oncol; 2006 Sep 23; 29(3):713-9. PubMed ID: 16865289
    [Abstract] [Full Text] [Related]

  • 5. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
    Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M, Sata M.
    Cancer Res; 2006 May 01; 66(9):4826-34. PubMed ID: 16651438
    [Abstract] [Full Text] [Related]

  • 6. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
    Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, Kondo S, Priebe W, Kondo Y.
    Oncogene; 2007 Apr 12; 26(17):2435-44. PubMed ID: 17043651
    [Abstract] [Full Text] [Related]

  • 7. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 8. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
    Wu MH, Chen XY, Cai KR.
    Ai Zheng; 2009 Jan 15; 28(1):24-8. PubMed ID: 19448411
    [Abstract] [Full Text] [Related]

  • 9. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K, Hamasaki K, Ichikawa T, Arima K, Eguchi K, Ishii N.
    Oncol Rep; 2006 Aug 15; 16(2):389-92. PubMed ID: 16820920
    [Abstract] [Full Text] [Related]

  • 10. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Miyashita K, Shiraki K, Fuke H, Inoue T, Yamanaka Y, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T.
    Int J Mol Med; 2006 Aug 15; 18(2):249-56. PubMed ID: 16820931
    [Abstract] [Full Text] [Related]

  • 11. Anti-human hepatocellular carcinoma effects of tumor necrosis factor-related apoptosis-inducing ligand in vitro & in vivo.
    Guo BC, Xu YH.
    Acta Pharmacol Sin; 2001 Sep 15; 22(9):831-6. PubMed ID: 11749866
    [Abstract] [Full Text] [Related]

  • 12. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
    Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, Ishii M, Takashima H, Katagishi T, Kimura H, Minami M, Itoh Y, Kagawa K, Okanoue T.
    J Hepatol; 2006 Jun 15; 44(6):1074-82. PubMed ID: 16481065
    [Abstract] [Full Text] [Related]

  • 13. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.
    Chen KF, Su JC, Liu CY, Huang JW, Chen KC, Chen WL, Tai WT, Shiau CW.
    Cancer Lett; 2012 Aug 01; 321(1):27-35. PubMed ID: 22465052
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 15. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A.
    Prostate; 2008 Feb 15; 68(3):269-80. PubMed ID: 18163422
    [Abstract] [Full Text] [Related]

  • 16. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z, Bradner J, Greenberg E, Mazitschek R, Foster R, Mahoney J, Seiden MV.
    Mol Pharmacol; 2007 Nov 15; 72(5):1137-45. PubMed ID: 17675586
    [Abstract] [Full Text] [Related]

  • 17. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y, Harada K, Ferdous T, Yoshida H.
    Anticancer Res; 2007 Nov 15; 27(4B):2365-75. PubMed ID: 17695527
    [Abstract] [Full Text] [Related]

  • 18. Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3.
    Chen KF, Tai WT, Liu TH, Huang HP, Lin YC, Shiau CW, Li PK, Chen PJ, Cheng AL.
    Clin Cancer Res; 2010 Nov 01; 16(21):5189-99. PubMed ID: 20884624
    [Abstract] [Full Text] [Related]

  • 19. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY, Kim GY, Kim ND, Jung JH, Kim SK, Kang HS, Choi YH.
    Oncol Rep; 2008 Feb 01; 19(2):517-26. PubMed ID: 18202802
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
    Fang F, Wang AP, Yang SF.
    Acta Pharmacol Sin; 2005 Nov 01; 26(11):1373-81. PubMed ID: 16225761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.